CELL
PhenomeX Inc. Common Stock
CELL
CELL
Delisted
CELL was delisted on the 29th of September, 2023.
116 hedge funds and large institutions have $130M invested in PhenomeX Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $138M → $130M (-$8.24M)
Holders
116
Holding in Top 10
1
Calls
$149K
Puts
$34K
Top Buyers
| 1 | +$3.73M | |
| 2 | +$3.56M | |
| 3 | +$2.94M | |
| 4 |
Millennium Management
New York
|
+$2.81M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.45M |
Top Sellers
| 1 | -$7.25M | |
| 2 | -$6.35M | |
| 3 | -$2.58M | |
| 4 |
BlackRock
New York
|
-$836K |
| 5 |
Lazard Asset Management
New York
|
-$678K |